ข่าวประชาสัมพันธ์Fibromyalgia | newswit
New Survey Suggests Hidden Burden of Chronic Pain in Fibromyalgia Patients in Asia – Bangkok--28 Oct--Weber Shandwick Fibromyalgia is chronic pain that is commonly overlooked because of a complex of symptoms, leading to delays in diagnosis A new South East Asian survey of 506 people with fibromyalgia and 941 physicians shows that fibromyalgia is a poorly understood and debilitating, chronic, widespread pain condition, which
European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia – The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a negative opinion on a Cymbalta(R) (duloxetine hydrochloride) application for the treatment of fibromyalgia. "Eli Lilly and Company and Boehringer Ingelheim are naturally disappointedby the CHMP's opinion," said James Russell,
New Global Survey Exposes Considerable Burden of Fibromyalgia Including Potential Economic Impact – - Lack of Physician Education May Contribute to ProblemA new global survey of fibromyalgia patients and physicians shows that fibromyalgia, a chronic widespread pain condition, results in poor quality oflife and poses a financial burden on patients often resulting in an inability to work and earn income. The burden of fibromyalgia